Literature DB >> 12579541

Alpha-actin isoform distribution in normal and failing human heart: a morphological, morphometric, and biochemical study.

Albert J H Suurmeijer1, Sophie Clément, Arianna Francesconi, Leonardo Bocchi, Annalisa Angelini, Dirk J Van Veldhuisen, Luigi Giusto Spagnoli, Giulio Gabbiani, Augusto Orlandi.   

Abstract

We investigated the distribution of alpha-skeletal, alpha-cardiac, and alpha-smooth muscle actin isoforms in human heart during development, hypertrophy, and failure. At 20 weeks of fetal life, alpha-skeletal actin was localized in a small proportion of subendocardial and papillary muscle cardiomyocytes. At this gestation time, diffuse alpha-cardiac actin staining was observed, associated with focal expression of alpha-smooth muscle actin. In normal adult subjects, alpha-skeletal actin positive cardiomyocytes were distributed in a transmural gradient with the highest proportion located subendocardially. In myocardial hypertrophy and cardiomyopathies, the amount of alpha-skeletal actin was increased and diffuse staining was seen in all layers of ventricular myocardium, with the exception of idiopathic dilated cardiomyopathies. Cardiomyocytes were negative for alpha-smooth muscle actin in all pathological situations studied. As expected, fibroblasts in post-infarct scars expressed alpha-smooth muscle actin and transforming growth factor-beta1 but, surprisingly, were negative for these proteins in interstitial fibrosis. Our results demonstrate that increased expression of alpha-skeletal actin in the diseased human heart is associated with increased myocyte stretch, increased wall stress, and pressure overload, but not with idiopathic dilated cardiomyopathies. They also suggest that fibrotic changes develop with different mechanisms in scars versus interstitial fibrosis. Copyright 2003 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12579541     DOI: 10.1002/path.1311

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  38 in total

Review 1.  Myofibrillar remodeling in cardiac hypertrophy, heart failure and cardiomyopathies.

Authors:  Jarmila Machackova; Judit Barta; Naranjan S Dhalla
Journal:  Can J Cardiol       Date:  2006-09       Impact factor: 5.223

2.  Effects of chronic treatment with the new ultra-long-acting β2 -adrenoceptor agonist indacaterol alone or in combination with the β1 -adrenoceptor blocker metoprolol on cardiac remodelling.

Authors:  Barbara Rinaldi; Maria Donniacuo; Loredana Sodano; Giulia Gritti; Eugenio Martuscelli; Augusto Orlandi; Concetta Rafaniello; Francesco Rossi; Luigino Calzetta; Annalisa Capuano; Maria Gabriella Matera
Journal:  Br J Pharmacol       Date:  2015-05-12       Impact factor: 8.739

3.  New insights into the molecular phenotype of eccentric hypertrophy.

Authors:  Sebastiano Sciarretta; Junichi Sadoshima
Journal:  J Mol Cell Cardiol       Date:  2010-04-08       Impact factor: 5.000

Review 4.  Cardiomyocyte maturation: advances in knowledge and implications for regenerative medicine.

Authors:  Elaheh Karbassi; Aidan Fenix; Silvia Marchiano; Naoto Muraoka; Kenta Nakamura; Xiulan Yang; Charles E Murry
Journal:  Nat Rev Cardiol       Date:  2020-02-03       Impact factor: 32.419

5.  An Unbiased Proteomics Method to Assess the Maturation of Human Pluripotent Stem Cell-Derived Cardiomyocytes.

Authors:  Wenxuan Cai; Jianhua Zhang; Willem J de Lange; Zachery R Gregorich; Hannah Karp; Emily T Farrell; Stanford D Mitchell; Trisha Tucholski; Ziqing Lin; Mitch Biermann; Sean J McIlwain; J Carter Ralphe; Timothy J Kamp; Ying Ge
Journal:  Circ Res       Date:  2019-10-01       Impact factor: 17.367

6.  A protective antiarrhythmic role of ursodeoxycholic acid in an in vitro rat model of the cholestatic fetal heart.

Authors:  Michele Miragoli; Siti H Sheikh Abdul Kadir; Mary N Sheppard; Nicoló Salvarani; Matilda Virta; Sarah Wells; Max J Lab; Viacheslav O Nikolaev; Alexey Moshkov; William M Hague; Stephan Rohr; Catherine Williamson; Julia Gorelik
Journal:  Hepatology       Date:  2011-08-01       Impact factor: 17.425

7.  Molecular mechanism of the E99K mutation in cardiac actin (ACTC Gene) that causes apical hypertrophy in man and mouse.

Authors:  Weihua Song; Emma Dyer; Daniel J Stuckey; O'Neal Copeland; Man-Ching Leung; Christopher Bayliss; Andrew Messer; Ross Wilkinson; Jordi Lopez Tremoleda; Michael D Schneider; Sian E Harding; Charles S Redwood; Kieran Clarke; Kristen Nowak; Lorenzo Monserrat; Dominic Wells; Steven B Marston
Journal:  J Biol Chem       Date:  2011-05-26       Impact factor: 5.157

Review 8.  Sarcomeric protein isoform transitions in cardiac muscle: a journey to heart failure.

Authors:  Zhiyong Yin; Jun Ren; Wei Guo
Journal:  Biochim Biophys Acta       Date:  2014-11-08

9.  Investigation of changes in skeletal muscle alpha-actin expression in normal and pathological human and mouse hearts.

Authors:  O'Neal Copeland; Kristen J Nowak; Nigel G Laing; Gianina Ravenscroft; Andrew E Messer; Christopher R Bayliss; Steven B Marston
Journal:  J Muscle Res Cell Motil       Date:  2010-08-13       Impact factor: 2.698

Review 10.  Remodeling and dedifferentiation of adult cardiomyocytes during disease and regeneration.

Authors:  Marten Szibor; Jochen Pöling; Henning Warnecke; Thomas Kubin; Thomas Braun
Journal:  Cell Mol Life Sci       Date:  2013-12-10       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.